Hong Kong
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
33.85%
|
Dec. 31, 2023 | USD 0.93 | 2.39% |
|
Hong Kong |
|
2 |
25.96%
|
Dec. 31, 2023 | USD 0.44 | 1.16% |
|
Hong Kong |
|
3 |
25.36%
|
Dec. 31, 2023 | USD 0.41 | 0.30% |
|
Hong Kong |
|
4 |
23.94%
|
Dec. 31, 2023 | USD 1.48 | 0.68% |
|
Hong Kong |
|
5 |
23.63%
|
Dec. 31, 2023 | USD 0.19 | -0.02% |
|
Hong Kong |
|
6 |
22.08%
|
Dec. 31, 2023 | USD 0.38 | 2.08% |
|
Hong Kong |
|
7 |
7.88%
|
Dec. 31, 2023 | USD 0.25 | -2.07% |
|
Hong Kong |
|
8 |
7.78%
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
9 |
3.86%
|
Dec. 31, 2023 | USD 0.80 | 2.57% |
|
Hong Kong |
|
10 |
3.42%
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
11 |
2.19%
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
12 |
-49.12%
|
Dec. 31, 2023 | USD 17.19 | 2.12% |
|
Hong Kong |
|
13 |
-238.73%
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
14 |
-16,818.68%
|
Dec. 31, 2023 | USD 0.13 | -0.02% |
|
Hong Kong |
|
15 |
-19,432.24%
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
The Biotechnology company in Hong Kong with the highest Operating Income Margin is China Medical System Holdings Limited (HKSE: 0867.HK) at 33.85%.
The Biotechnology company in Hong Kong with the lowest Operating Income Margin is Sirnaomics Ltd. (HKSE: 2257.HK) at -19,432.24%.
The top 10 Biotechnology companies in Hong Kong by Operating Income Margin are China Medical System Holdings Limited, OrbusNeich Medical Group Holdings Limited, SSY Group Limited, The United Laboratories International Holdings Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited, Sino Biopharmaceutical Limited, China Traditional Chinese Medicine Holdings Co. Limited, Frontage Holdings Corporation, Guangdong Hybribio Biotech Co.,Ltd. and Lee's Pharmaceutical Holdings Limited.
The bottom 10 Biotechnology companies in Hong Kong by Operating Income Margin are Sirnaomics Ltd., SinoMab BioScience Limited, Prenetics Global Limited, BeiGene, Ltd., HUTCHMED (China) Limited, Lee's Pharmaceutical Holdings Limited, Guangdong Hybribio Biotech Co.,Ltd., Frontage Holdings Corporation, China Traditional Chinese Medicine Holdings Co. Limited and Sino Biopharmaceutical Limited.